Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × darinaparsin × Plasma cell × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 137 Lenalidomide 58 Bortezomib 54 Calcium Dobesilate 47 Melphalan 44 carfilzomib 40 Cyclophosphamide 38 pomalidomide 37 daratumumab 27 belantamab mafodotin 21 ixazomib 19 Peripheral Blood Stem Cell Transplantation 18 fludarabine phosphate 16 fludarabine 16 dexamethasone acetate 14 Bendamustine Hydrochloride 14 Whole-Body Irradiation 13 Filgrastim 13 dexamethasone 21-phosphate 12 Tacrolimus 12 venetoclax 11 auricularum 11 Prednisone 11 selinexor 10 liposomal doxorubicin 10 Mycophenolic Acid 10 iberdomide 9 Cyclosporine 9 pembrolizumab 8 Busulfan 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303199 2012-07-19

Study of ZIO-101 in Multiple Myeloma

Alaunos Therapeutics

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡